Molecular diagnostics are the key drivers in a more individualized pharmacotherapy
such as personalized and precision medicine. The Dx-Rx Institute is committed to working
with drug-diagnostic co-development and has been involved in a number of collaborations
with both academia and commercial partners, which includes several PMA submissions on
companion diagnostics. In addition to these activities the Dx-Rx Institute has taken part
in educational activities at several European Universities and has published a number of articles
on companion diagnostics and individualized pharmacotherapy, especially within oncology.
The Dx-Rx Institute was established in 2009 by Dr. Jan Trøst Jørgensen as an independent institution
where advice/consultancy goes hand in hand with research and development.
Please visit the company profile at Linked